Enzon

  www.enzon.com
  www.enzon.com

Enzon Reviews

5 Reviews
2.9
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
(no image)
Alexander J. (Alex) Denner
1 Rating
  1.  

    Excellent small biopharmaceutical company.

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Enzon full-time (more than 3 years)

    Pros

    Wonderful people to work with; good exposure to many different jobs in the pharma world. Employees are treated very nicely. Work environment is good.

    Cons

    Company has had several downsizings over the past few years. We lost many good people. Lost talent is hard to replace.

    Advice to ManagementAdvice

    Get some more products in the pipeline.

    Recommends
    Negative Outlook
    Disapproves of CEO

Enzon Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.enzon.com
Headquarters Piscataway, NJ
Size 150 to 499 Employees
Founded Unknown
Type Company - Public (ENZN)
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

Enzon Pharmaceuticals has PEGged its future on researching ways to fight cancer. The company is focused on developing compounds using its PEGylation technology and other platforms to improve the performance and deliverability of existing cancer drugs. PEGylation involves custom attaching polyethylene glycol (PEG) to a drug compound in order to make it more effective and less toxic for patients. Lead candidate PEG-SN38 uses PEGylation to increase exposure of cancer cells to SN38, the active metabolite of a chemotherapy drug marketed as Camptosar in the US.

Work at Enzon? Share Your Experiences

Enzon

 
Click to Rate
or